Treatment of pain by brain stimulation

• US 8,467,879 B1
• Filed: 10/14/2005
• Issued: 06/18/2013
• Est. Priority Date: 07/05/2001
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Inventors: Whitehurst, Todd K, Woods, Carla M, Meadows, Paul M
• Primary Examiner(s): Heller, Tammie K
• Application Number:
  US11/251,345
• Time in Patent Office: 2,804 Days
• Field of Search: 607/3, 607/46, 607/47
• US Class Current: 607/46
• CPC Class Codes: A61N 1/0531 Brain cortex electrodes
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/0539 Anchoring of brain electrode systems, e.g. within burr hole
• CPC Class Codes: A61N 1/36071 Pain

Abstract

Systems and methods for introducing one or more stimulating drugs and/or applying electrical stimulation to the brain to alleviate pain use at least one implantable system control unit (SCU), producing electrical pulses delivered via electrodes implanted in the brain and/or producing drug infusion pulses, wherein the stimulation is delivered to targeted areas in the brain. In some embodiments, one or more sensed conditions are used to adjust stimulation parameters.

Claims

1. A method, comprising:

implanting at least one system control unit within a patient with pain;

generating at least one stimulus with the system control unit in accordance with one or more stimulation parameters configured to treat the pain;

applying the at least one stimulus to at least one area of the brain of the patient; and

sensing at least one condition and using the at least one sensed condition to automatically determine the at least one stimulus to apply;

wherein the area of the brain is selected from at least one of the cingulate gyrus, the medial lemniscus, and the internal capsule.

2. The method of claim 1 wherein the at least one stimulus includes at least one stimulating drug.

3. The method of claim 2 wherein the at least one stimulating drug increases excitement of at least one area of the brain affecting pain that exhibits chronic decreased activity.

4. The method of claim 2 wherein the stimulating drug is at least one of an excitatory neurotransmitter agonist, an inhibitory neurotransmitter antagonist, an agent that increases a level of an excitatory neurotransmitter, an agent that decreases a level of an inhibitory neurotransmitter, and an analgesic medication.

5. The method of claim 2 wherein the at least one stimulating drug decreases excitement of at least one area of the brain affecting pain that exhibits chronic increased activity.

6. The method of claim 2 wherein the at least one stimulating drug is at least one of MK801, an agonist thereof, and an opiate.

7. The method of claim 2 wherein the at least one stimulus further comprises electrical stimulation.

8. The method of claim 1 wherein the at least one stimulus comprises electrical stimulation.

9. The method of claim 8 wherein the at least one system control unit is connected to at least two electrodes, and wherein the electrical stimulation is delivered via at least one of the at least two electrodes.

10. The method of claim 8, wherein the electrical stimulation is delivered at a frequency less than 100 Hz.

11. The method of claim 8, wherein the electrical stimulation is delivered at a frequency greater than 100 Hz.

12. The method of claim 1 wherein the at least one sensed condition is at least one of electrical activity of a neural population, impedance, pH, muscle activity, neural activity, acceleration, a neurotransmitter level, change in a neurotransmitter level, a neurotransmitter breakdown product level, change in a neurotransmitter breakdown product level, a medication level, change in a medication level, a drug level, change in a drug level, a hormone level, change in a hormone level, an interleukin level, change in an interleukin level, a cytokine level, change in a cytokine level, a lymphokine level, change in a lymphokine level, a chemokine level, change in a chemokine level, a growth factor level, change in a growth factor level, an enzyme level, change in an enzyme level, a ketone level, change in a ketone level, an electrolyte level, change in an electrolyte level, level of a substance in the blood plasma, change in level of a substance in the blood plasma, level of a substance in the local interstitial fluid, change in level of a substance in the local interstitial fluid, level of a substance in the cerebrospinal fluid, and change in level of a substance in the cerebrospinal fluid.

13. The method of claim 1, wherein the area of the brain is the cingulate gyrus.

14. The method of claim 1, wherein the area of the brain is the medial lemniscus.

15. A method, comprising:

implanting at least one system control unit within a patient with pain;

generating at least one stimulus with the system control unit in accordance with one or more stimulation parameters configured to treat the pain; and

applying the at least one stimulus to at least one area of the brain of the patient;

wherein the area of the brain is selected from at least one of the cingulate gyrus, the medial lemniscus, and the internal capsule;

wherein the at least one stimulus comprises at least one stimulating drug and electrical stimulation.

16. The method of claim 15 further comprising sensing at least one condition and using the at least one sensed condition to automatically determine the stimulus to apply, wherein the at least one sensed condition is at least one of electrical activity of a neural population, impedance, pH, muscle activity, neural activity, acceleration, a neurotransmitter level, change in a neurotransmitter level, a neurotransmitter breakdown product level, change in a neurotransmitter breakdown product level, a medication level, change in a medication level, a drug level, change in a drug level, a hormone level, change in a hormone level, an interleukin level, change in an interleukin level, a cytokine level, change in a cytokine level, a lymphokine level, change in a lymphokine level, a chemokine level, change in a chemokine level, a growth factor level, change in a growth factor level, an enzyme level, change in an enzyme level, a ketone level, change in a ketone level, an electrolyte level, change in an electrolyte level, level of a substance in the blood plasma, change in level of a substance in the blood plasma, level of a substance in the local interstitial fluid, change in level of a substance in the local interstitial fluid, level of a substance in the cerebrospinal fluid, and change in level of a substance in the cerebrospinal fluid.

17. The method of claim 15, wherein the electrical stimulation is delivered at a frequency less than 100 Hz.

18. The method of claim 15, wherein the electrical stimulation is delivered at a frequency greater than 100 Hz.

19. The method of claim 15, wherein the area of the brain is the cingulate gyrus.

20. The method of claim 15, wherein the area of the brain is the medial lemniscus.